Skip to main content
Feb 5-7, 2027
Miami
Register
Program
Agenda
CE Information
Get to Know LL&M Winter Symposium
Faculty
Hotel & Travel
Pricing
Exhibitors & Sponsors
Press Information
The Official Meeting of
Oncology Learning Network
Agenda
Agenda
February 7-9, 2025 | Fontainebleau Miami Beach
Register
February 5-7, 2027
Scroll previous
Friday
February 7
Saturday
February 8
Sunday
February 9
Scroll next
Friday February 07, 2025
12:00 PM – 1:00 PM
Innovation Theater/Symposium (Non-Accredited) (Sponsored by AbbVie)
Title: Practical Management of AML with a BCL-2 Inhibitor Speaker: Ashish A. Shah, DO, MSc
1:00 PM – 3:00 PM
Leukemia Landscape: Research and Clinical Advances (Part 1)
1:00 PM – 1:20 PM
Updates in the Diagnosis and Classification of Myeloid Malignancies
1:20 PM – 1:40 PM
Updates in Low/Intermediate Risk Myelodysplastic Syndromes
1:40 PM – 2:00 PM
Updates in High-Risk Myelodysplastic Syndromes
2:00 PM – 2:20 PM
Updates in Chronic Myeloid Leukemia
2:20 PM – 2:40 PM
From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
2:40 PM – 3:00 PM
Question & Answer Panel
3:00 PM – 3:30 PM
Exhibit Hall
3:30 PM – 5:30 PM
Leukemia Landscape: Research and Clinical Advances (Part 2)
3:30 PM – 3:50 PM
Updates in Myeloproliferative Neoplasms
3:50 PM – 4:10 PM
Updates in Acute Lymphoblastic Leukemia
4:10 PM – 4:30 PM
Updates in Front Line Acute Myeloid Leukemia
4:30 PM – 4:50 PM
Updates in Relapsed Acute Myeloid Leukemia
4:50 PM – 5:10 PM
From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
5:10 PM – 5:30 PM
Question & Answer Panel
5:30 PM – 6:30 PM
Innovation Theater/Symposium (Non-Accredited) (Sponsored by Amgen)
Title: Latest Innovations in Frontline Consolidation CD19-positive Ph (-) B-Cell Precursor ALL Speaker: Nikesh Shah, MD
6:30 PM – 7:30 PM
Exhibit Hall Welcome Reception
Saturday February 08, 2025
7:30 AM – 8:30 AM
Innovation Theater/Symposium (Non-Accredited) (Sponsored by AbbVie)
Title: Optimizing the Patient Journey: The Path of Least Resistance Speakers: Matthew S. Davids, MD, MMSc Joanna M. Rhodes, MD, MSCE
8:30 AM – 10:30 AM
CLL Landscape: Research and Clinical Advances
This session has been supported by an independent medical education grant from AstraZeneca.
8:30 AM – 8:50 AM
Updates in New Classifications and Risk Stratifications
8:50 AM – 9:10 AM
Updates in Bispecific Antibodies, Degraders, CAR-T Cells
9:10 AM – 9:30 AM
Updates in BTKi + BCL2 Therapy in the Retreatment Population
9:30 AM – 9:50 AM
Updates in the Management of BTK Resistance & Mutations
9:50 AM – 10:10 AM
From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
10:10 AM – 10:30 AM
Question & Answer Panel
10:30 AM – 11:00 AM
Exhibit Hall
11:00 AM – 1:00 PM
Multiple Myeloma Landscape: Research and Clinical Advances (Part 1)
This session has been supported by an independent medical education grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, both are Johnson and Johnson companies.
11:00 AM – 11:20 AM
Updates in basic science, pathophysiology, and diagnosis (including MRD & P53)
11:20 AM – 11:40 AM
Updates in Precursor Disorders
11:40 AM – 12:00 PM
Updates in Front Line – Transplant Eligible Multiple Myeloma
12:00 PM – 12:20 PM
Updates in Front Line – Transplant Ineligible Multiple Myeloma
12:20 PM – 12:40 PM
From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
12:40 PM – 1:00 PM
Question & Answer Panel
1:00 PM – 2:00 PM
Innovation Theater/Symposium (Non-Accredited) (Sponsored by Johnson & Johnson)
Title: What's Next for Patients with 2L+ Relapsed or Refractory Multiple Myeloma Speaker: Melhem Solh, MD
2:00 PM – 2:30 PM
Exhibit Hall
2:30 PM – 4:30 PM
Multiple Myeloma Landscape: Research and Clinical Advances (Part 2)
2:30 PM – 2:50 PM
Updates in Relapsed Disease
2:50 PM – 3:10 PM
Updates in Relapsed or Refractory CAR-T Therapy
3:10 PM – 3:30 PM
Updates in Relapsed or Refractory Bispecific Antibody Treatment
3:30 PM – 3:50 PM
Updates in Relapsed or Refractory Novel Agents
3:50 PM – 4:10 PM
From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
4:10 PM – 4:30 PM
Question & Answer Panel
4:30 PM – 5:30 PM
Innovation Theater/Symposium (Non-Accredited) (Sponsored by Johnson & Johnson)
Title: TECVAYLI Overview & DARZALEX FASPRO PERSEUS Trial Speaker: Taewoong Choi, MD Assistant Professor, Duke University School of Medicine, Durham, NC
5:40 PM – 6:40 PM
Evening Reception
Room
Seagreen Lawn
Sunday February 09, 2025
7:30 AM – 8:30 AM
Innovation Theater/Symposium (Non-Accredited) (Sponsored by Eli Lilly and Company)
Title: Learn about an alternative treatment for certain B-cell malignancies. This program is sponsored by Lilly USA, LLC. Speaker: Julio Chavez, MD, MS
8:30 AM – 10:30 AM
Lymphoma Landscape: Research and Clinical Advances (Part 1)
This session has been supported by independent medical education grants from ADC Therapeutics America, Inc and Genentech, a member of the Roche Group.
8:30 AM – 8:50 AM
Updates in Basic Science and Diagnostic Classification: Relapsed/Refractory Diffuse Large B-Cell Lymphoma Microenvironment Archetypes (LymphoMAPs)
8:50 AM – 9:10 AM
Updates in Frontline Treatment of Diffuse Large B-Cell Lymphoma
9:10 AM – 9:30 AM
Updates in Relapsed Diffuse Large B-Cell Lymphoma
9:30 AM – 9:50 AM
Updates in Mantle Cell Lymphoma and Marginal Zone Lymphoma
9:50 AM – 10:10 AM
From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
10:10 AM – 10:30 AM
Question & Answer Panel
10:30 AM – 10:45 AM
Coffee Break
10:45 AM – 12:45 PM
Lymphoma Landscape: Research and Clinical Advances (Part 2)
This session has been supported by independent medical education grants from ADC Therapeutics America, Inc and Genentech, a member of the Roche Group.
10:45 AM – 11:05 AM
Updates in Frontline Treatment of Follicular Lymphoma
11:05 AM – 11:25 AM
Updates in Treatment of Relapsed Follicular Lymphoma
11:25 AM – 11:45 AM
Updates in Hodgkin Lymphoma
11:45 AM – 12:05 PM
Updates in T-Cell Lymphoma
12:05 PM – 12:25 PM
From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
12:25 PM – 12:45 PM
Question & Answer Panel
Back to top
